• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Neurocrine Biosciences

Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Bayer taps new chief medical officer—Chutes & Ladders

Bayer taps new chief medical officer. Cantor steps into PhRMA’s house as CEO. Moderna veteran rejoins for second act.
Darren Incorvaia , Marissa Russo , Donavyn Coffey , James Waldron Oct 2, 2026 8:30am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

Biogen R&D vet gets in Formation—Chutes & Ladders

Jul 24, 2026 8:30am
parachute chutes

Eric Topol boards Flagship as advisor—Chutes & Ladders

Mar 20, 2026 8:30am
Lifeline

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm
colorful brain art model

Neurocrine-Takeda psychiatry pact suffers another phase 2 fail

Nov 11, 2025 6:25am
reshuffle pipeline target reorganize shift change

Neurocrine pens $880M pact with TransThera for immunology target

Nov 3, 2025 5:42am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings